The FDA reported on December 31, 2023, alerting parents, caregivers, and health care providers that Reckitt/Mead Johnson Nutrition has voluntarily recalled Nutramigen Hypoallergenic Infant Formula powder due to possible Cronobacter sakazakii contamination. No illnesses have been reported to date in connection with this recall. Likely, most of the products distributed in the U.S. have already been consumed. The Israeli Ministry of Health notified the FDA on December 14 that Nutramigen Hypoallergenic Powdered Infant Formula, produced at the Mead Johnson Nutrition Zeeland, Michigan, facility and exported from the U.S., had initially tested positive for Cronobacter species. The product was tested at the Israeli border during routine sampling. The FDA immediately took investigative steps. They initiated WGS on the sample obtained from the infant formula to confirm the initial findings of Cronobacter species. The FDA started inspection at Reckitt/Mead Johnson Nutrition's Zeeland facility on December 18. All testing conducted by the FDA and Reckitt/Mead Johnson Nutrition has been negative for Cronobacter. On December 28, the FDA received the WGS results from Israeli health officials, which confirmed a finding of Cronobacter sakazakii. The FDA immediately contacted Mead Johnson Nutrition and recommended a recall. On December 29, Reckitt/Mead Johnson Nutrition agreed to initiate a voluntary recall of 675,030 cans of Nutramigen powdered infant formula distributed to the United States. @ https://www.fda.gov/food/cfsan-constituent-updates/reckittmead-johnson-nutrition-voluntarily-recalls-certain-nutramigen-hypoallergenic-powdered-infant?utm_medium=email&utm_source=govdelivery
